The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings
- 18 April 2008
- journal article
- review article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 23 (5), 355-370
- https://doi.org/10.1002/hup.940
Abstract
Objectives The loudness dependence of the auditory evoked potential (LDAEP) has been proposed as a valid means of non‐invasively assessing in vivo central serotonin (5‐hydroxytryptamine, 5‐HT) function in humans. The specificity and sensitivity of the LDAEP to changes in 5‐HT neurotransmission have recently been explored directly in a number of pharmacological and genetic studies. Subsequently, this review was undertaken in an attempt to critically evaluate the potential role of the LDAEP as a marker of the central 5‐HT function. Design Findings from clinical, experimental animal and human studies examining the relationship between the LDAEP and the 5‐HT system as well as other neurochemical systems including dopaminergic, glutamatergic and the cholinergic systems were reviewed. Results The majority of evidence for an association between the LDAEP and 5‐HT has come from animal studies. Indirect studies in clinical disorders of presumed serotonergic dysfunction have been circumstantial and inconsistent with more recent investigations utilising direct genetic association studies also providing conflicting reports. Pharmacological studies in humans provide overwhelming evidence that the LDAEP is insensitive to acute changes in 5‐HT function, with additional evidence outlining sensitivity to other neurotransmitter systems including the glutamatergic system. Conclusions The available evidence suggests that the LDAEP lacks sensitivity and specificity to acute changes in serotonergic neurotransmission. Overall the findings do not provide strong support for its utility as a marker of central 5‐HT function. However the LDAEP shows more promise as a potential predictor of antidepressant treatment response and this predictive ability may provide the basis for future research involving the LDAEP. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 131 references indexed in Scilit:
- The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differencesJournal of Affective Disorders, 2007
- Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAMJournal of Neural Transmission, 2006
- Modulation of Striatal Dopamine Release by Glycine Transport InhibitorsNeuropsychopharmacology, 2005
- The intensity dependence of the auditory evoked N1 component as a predictor of reponse to Citalopram treatment in patients with major depressionNeuroscience Letters, 2004
- Decreasing Amphetamine-Induced Dopamine Release by Acute Phenylalanine/Tyrosine Depletion: A PET/[11C]Raclopride Study in Healthy MenNeuropsychopharmacology, 2003
- Simultaneous depletion of tryptophan, tyrosine and phenylalanine as an experimental method to probe brain monoamine function in humansInternational Journal of Neuropsychopharmacology, 1999
- Modulation of NMDA receptors by glycine ? introduction to some basic aspects and recent developmentsAmino Acids, 1998
- Glutamate receptor agonists decrease extracellular dopamine in the rat nucleus accumbens in vivoSynapse, 1996
- Peripheral Indices of Central Serotonin Function in HumansAnnals of the New York Academy of Sciences, 1990
- Platelets as models: Use and limitationsCellular and Molecular Life Sciences, 1988